相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resting state quantitative electroencephalogram gamma power spectra in patients with first episode psychosis: An observational study
Shailly Yadav et al.
ASIAN JOURNAL OF PSYCHIATRY (2021)
The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects
Laura F. Cavallone et al.
PAIN (2020)
Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice
David D. Aguilar et al.
JOURNAL OF NEUROPHYSIOLOGY (2020)
A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology
Daniel C. Javitt et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Modulation of arousal and sleep/wake architecture by M1PAM VU0453595 across young and aged rodents and nonhuman primates
Robert W. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Depression and Sleep
Axel Steiger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep-wake cycle
Susanne Weigend et al.
SLEEP (2019)
Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M4 PAM VU0467154
Robert W. Gould et al.
NEUROPHARMACOLOGY (2018)
Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors
Nathanael O'Neill et al.
JOURNAL OF NEUROSCIENCE (2018)
Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation
Andrew S. Felts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The homeostatic and circadian sleep recovery responses after total sleep deprivation in mice
Garance Dispersyn et al.
JOURNAL OF SLEEP RESEARCH (2017)
Effects of Antidepressants on Sleep
Adam Wichniak et al.
CURRENT PSYCHIATRY REPORTS (2017)
Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias
K. Sengmany et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects
Robert W. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The Gut-Brain Axis, BDNF, NMDA and CNS Disorders
Raeesah Maqsood et al.
NEUROCHEMICAL RESEARCH (2016)
State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154-Relation to antipsychotic-like drug effects
Robert W. Gould et al.
NEUROPHARMACOLOGY (2016)
Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model
Alison Hamilton et al.
CELL REPORTS (2016)
A Rodent Model of Traumatic Stress Induces Lasting Sleep and Quantitative Electroencephalographic Disturbances
Michael T. Nedelcovych et al.
ACS CHEMICAL NEUROSCIENCE (2015)
MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia
John Talpos et al.
PSYCHOPHARMACOLOGY (2015)
Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats
A. Ahnaou et al.
PSYCHOPHARMACOLOGY (2015)
Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice
Aubin Michalon et al.
BIOLOGICAL PSYCHIATRY (2014)
Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia
Brett A. English et al.
BIOMARKERS IN MEDICINE (2014)
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine - a quantitative EEG study in rats
S. C. Leiser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral
Travis Rush et al.
CELL AND TISSUE RESEARCH (2014)
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
G. Sanacora et al.
MOLECULAR PSYCHIATRY (2014)
Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms
Tetsuaki Hiyoshi et al.
NEUROPHARMACOLOGY (2014)
The touchscreen operant platform for testing learning and memory in rats and mice
Alexa E. Horner et al.
NATURE PROTOCOLS (2013)
Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors
B. D. Harvey et al.
NEUROPHARMACOLOGY (2013)
ACUTE N-METHYL-D-ASPARTATE RECEPTOR HYPOFUNCTION INDUCED BY MK801 EVOKES SEX-SPECIFIC CHANGES IN BEHAVIORS OBSERVED IN OPEN-FIELD TESTING IN ADULT MALE AND PROESTRUS FEMALE RATS
I. Feinstein et al.
NEUROSCIENCE (2013)
Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat
Maria Cavas et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Sleep as a biomarker for depression
Adam Wichniak et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia
K. G. Phillips et al.
NEUROPHARMACOLOGY (2012)
Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways
John Meitzen et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
A new look at gamma? High- (>60 Hz) γ-band activity in cortical networks: Function, mechanisms and impairment
Peter J. Uhlhaas et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine
M. M. J. Veeneman et al.
PSYCHOPHARMACOLOGY (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Metabotropic glutamate receptor subtype 5 antagonism in learning and memory
Agnes Simonyi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
Maria-Antonia Quera-Salva et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Wake and sleep EEG provide biomarkers in depression
Axel Steiger et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Nicotine-induced conditioned place preference in rats: Sex differences and the role of mGluR5 receptors
Gorkem Yararbas et al.
NEUROPHARMACOLOGY (2010)
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
Nicolas Morin et al.
NEUROPHARMACOLOGY (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
Michael C. Montana et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease
Elvira De Leonibus et al.
NEUROPSYCHOPHARMACOLOGY (2009)
A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease
J. C. Talpos et al.
PSYCHOPHARMACOLOGY (2009)
Executive deficits in psychotic and bipolar disorders - Implications for our understanding of schizoaffective disorder
Andrei Szoke et al.
EUROPEAN PSYCHIATRY (2008)
Sleep and circadian rhythms in mood disorders
R. Armitage
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Behavioural pharmacology: 40+years of progress, with a focus on glutamate receptors and cognition
TW Robbins et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
A close structural analog of 2-methyl-6-(phenylethynyl)pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators
AL Rodriguez et al.
MOLECULAR PHARMACOLOGY (2005)
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
CJ Swanson et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release
H Homayoun et al.
NEUROPSYCHOPHARMACOLOGY (2004)
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine, (MTEP) in rodent models of anxiety
CS Busse et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Glutamate-receptor-mediated encoding and retrieval of paired-associate learning
M Day et al.
NATURE (2003)
Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents
GG Kinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse
AJ McGeehan et al.
SYNAPSE (2003)
Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys
MA Taffe et al.
PSYCHOPHARMACOLOGY (2002)
Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies
M. J. Marino et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons
A Pisani et al.
NEUROSCIENCE (2001)
分享论文
